Cargando…

Carrier Frequency of Spinal Muscular Atrophy in a Large-scale Korean Population

Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by progressive proximal muscle weakness and atrophy. Given the recent introduction of gene therapies, knowledge of the SMA carrier frequency in various populations has become important for developing screening programs for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jong Eun, Yun, Sun Ae, Roh, Eun Youn, Yoon, Jong Hyun, Shin, Sue, Ki, Chang-Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054693/ https://www.ncbi.nlm.nih.gov/pubmed/32067433 http://dx.doi.org/10.3343/alm.2020.40.4.326

Ejemplares similares

Spinal muscular atrophy carrier frequency in Saudi Arabia
por: Al Jumah, Mohammed, et al.
Publicado: (2022)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Genetics of low spinal muscular atrophy carrier frequency in sub‐Saharan Africa
por: Sangaré, Modibo, et al.
Publicado: (2014)

Prevalence of granular corneal dystrophy type 2-related TGFBI p.R124H variant in a South Korean population
por: Park, Jong Eun, et al.
Publicado: (2021)

Performance of LIFECODES HLA-DQB1 Typing Kit Using Luminex Platform in Koreans
por: Roh, Eun Youn, et al.
Publicado: (2015)

Clinical Characteristics and Genotype-Phenotype Correlation of Korean Patients with Spinal and Bulbar Muscular Atrophy
por: Song, Ju Sun, et al.
Publicado: (2015)

Positivity of SARS-CoV-2 Antibodies among Korean Healthy Healthcare Workers 1 and 2 Weeks after Second Dose of Pfizer-BioNTech Vaccination
por: Kim, Namhee, et al.
Publicado: (2021)

Reliability and Validity of the Korean Version of the Spinal and Bulbar Muscular Atrophy Functional Rating Scale
por: Oh, Seong-il, et al.
Publicado: (2020)

Prevalence, incidence and carrier frequency of 5q–linked spinal muscular atrophy – a literature review
por: Verhaart, Ingrid E. C., et al.
Publicado: (2017)

Genotype-Phenotype Correlation of SMN1 and NAIP Deletions in Korean Patients with Spinal Muscular Atrophy
por: Ahn, Eun-Ji, et al.
Publicado: (2017)

Clinical Characteristics of Spinal Muscular Atrophy in Korea Confirmed by Genetic Analysis
por: Hwang, Heewon, et al.
Publicado: (2017)

Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals
por: Jang, Mi-Ae, et al.
Publicado: (2015)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Increased systemic HSP70B levels in spinal muscular atrophy infants
por: Eichelberger, Eric J., et al.
Publicado: (2021)

Combination disease‐modifying treatment in spinal muscular atrophy: A proposed classification
por: Proud, Crystal M., et al.
Publicado: (2023)

The prevalence of spinal muscular atrophy carrier in China: Evidences from epidemiological surveys
por: Li, Chao, et al.
Publicado: (2020)

Spinal muscular atrophy diagnosis and carrier screening from genome sequencing data
por: Chen, Xiao, et al.
Publicado: (2020)

Deletion of SMN and NAIP genes in Korean patients with spinal muscular atrophy.
por: Shin, S., et al.
Publicado: (2000)

Low fat diets increase survival of a mouse model of spinal muscular atrophy
por: Deguise, Marc‐Olivier, et al.
Publicado: (2019)

Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy
por: Pane, Marika, et al.
Publicado: (2022)

Epidural anesthesia for the patient with type IV spinal muscular atrophy -A case report-
por: Kim, Seon Jin, et al.
Publicado: (2010)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy Versus Matched Controls
por: Viscidi, Emma, et al.
Publicado: (2021)

Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

A consensus statement on spinal muscular atrophy management in Saudi Arabia in the context of COVID-19
por: Alghamdi, Fouad, et al.
Publicado: (2020)

Preparation of Internal Quality Control Material for Lymphocyte Subset Analysis
por: Roh, Eun Youn, et al.
Publicado: (2016)

Muscle: an independent contributor to the neuromuscular spinal muscular atrophy disease phenotype
por: Jha, Narendra N., et al.
Publicado: (2023)

How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy?
por: Uher, David, et al.
Publicado: (2023)

GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population
por: Cho, Hyun-Jung, et al.
Publicado: (2005)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Spinal Muscular Atrophy: The Treatment Approved
por: Tabet, Rabih, et al.
Publicado: (2017)

Advances in spinal muscular atrophy therapeutics
por: Parente, Valeria, et al.
Publicado: (2018)

Euglycemic Ketoacidosis in Spinal Muscular Atrophy
por: Stoimenis, Dimitrios, et al.
Publicado: (2019)

Metabolic Dysfunction in Spinal Muscular Atrophy
por: Deguise, Marc-Olivier, et al.
Publicado: (2021)

Update on Biomarkers in Spinal Muscular Atrophy
por: Pino, Megan G, et al.
Publicado: (2021)

Onasemnogene abeparvovec for spinal muscular atrophy
Publicado: (2022)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
por: Zilio, Eleonora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_afvks74394pr55qbeo3hjpb6hj